Tecentriq, Kesimpta lead latest SMC decisions by Lucy Parsons | Jul 13, 2021 | News | 0 SMC was unable to accept Pfizer’s Vyndaqel for use in patients with transthyretin amyloidosis Read More
Two medicines accepted for use by NHS Scotland by Selina McKee | Dec 8, 2020 | News | 0 Medicines for blood cancer and a rare muscle disorder will be made available for NHS patients Read More